Sort
82,697 grants matching “vaccine development”
HIV Prevention trials Network (HPTN) Coordinating and Operations Center
$8,661,342Sten H Vermund · Family Health International · U01 · FY2008 · AI
ARRA: Clinical Support for Universal Influenza Development
$8,654,779Barney Graham · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
NIAID HIV AND OTHER INFECTIOUS DISEASES CLINICAL RESEARCH SUPPORT SERVICES (CRSS)
$8,644,838Bambra Strokes · Ppd Development Lp · N01 · FY2017 · AI
A prospective study of critical environmental exposures in formative early life that impact lifelong health in rural US children: the New Hampshire Birth Cohort Study
$8,637,047Margaret Rita Karagas · Dartmouth College · UH3 · FY2025 · OD
DEVELOPMENT OF AN ORAL DRUG FOR SMALLPOX TREATMENT
$8,630,636George R Painter · Chimerix, Inc. · U01 · FY2006 · AI
Leadership for HIV/AIDS Clinical Trials Networks; HIV Vaccine Trials Network
$8,628,364Peter B. Gilbert · Fred Hutchinson Cancer Research Center · UM1 · FY2012 · AI
The Baltimore Longitudinal Study of Aging
$8,568,920Eleanor M Simonsick · National Institute On Aging · ZIA · FY2024 · AG
Malaria Transmission Blocking Vaccine Discovery
$8,566,689Patrick Duffy · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
CENTRAL LABORATORY FOR THE HIV VACCINES TRAILS NETWORK
$8,563,676Duke University · U01 · FY2004 · AI
Bioterrorism: Molecular Analysis and Intervention
$8,543,253University Of Chicago · U54 · FY2004 · AI
LC: HIV PREVENTION TRIALS NETWORK
$8,531,038Susan H Eshleman · Johns Hopkins University · UM1 · FY2025 · AI
HTS Core
$8,530,970Kristen A Johnson · Scripps Research Institute, The · U19 · FY2022 · AI
National Emerging Infectious Diseases Laboratories Operations
$8,500,000Ronald B Corley · Boston University Medical Campus · UC7 · FY2017 · AI
Statistical and Data Management Center-Pediatric,Adolescent, and Maternal CTG
$8,477,926David Eric Shapiro · Harvard School Of Public Health · UM1 · FY2011 · AI
DEVELOPMENT OF AN ORAL DRUG FOR SMALLPOX TREATMENT
$8,477,202Chimerix, Inc. · U01 · FY2005 · AI
Tulane National Primate Research Center
$8,473,941Lee Hamm · Tulane University Of Louisiana · P51 · FY2018 · OD
Tulane National Primate Research Center
$8,471,182Lee Hamm · Tulane University Of Louisiana · P51 · FY2019 · OD
Tulane National Primate Research Center
$8,470,444Lee Hamm · Tulane University Of Louisiana · P51 · FY2020 · OD
Tulane National Primate Research Center
$8,470,444Lee Hamm · Tulane University Of Louisiana · P51 · FY2022 · OD
Tulane National Primate Research Center
$8,470,444Lee Hamm · Tulane University Of Louisiana · P51 · FY2021 · OD
Leadership for HIV/AIDS Clinical Trials Networks; HIV Vaccine Trials Network
$8,458,351Steven G. Self · Fred Hutchinson Cancer Research Center · U01 · FY2007 · AI
COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE
$8,457,647Kathleen Neuzil · University Of Maryland Baltimore · N01 · FY2023 · AI
DEVELOPMENT OF AN ORAL DRUG FOR SMALLPOX TREATMENT
$8,448,207George R Painter · Chimerix, Inc. · U01 · FY2007 · AI
Production of a Broadly Neutralizing HIV Antibodies
$8,445,410Richard Schwartz · National Institute Of Allergy And Infectious Diseases · ZIB · FY2015 · AI
Medical Oncology Fellowship Program
$8,440,298Antonio Fojo · Basic Sciences · Z01 · FY2007 · CA